Free Trial

Pharming Group (PHAR) Short Interest Ratio & Short Volume

$8.04
-0.41 (-4.85%)
(As of 10/4/2024 ET)

Pharming Group Short Interest Data

Pharming Group (PHAR) has a short interest of 3,500 shares. This marks a 600.00% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 4,719 shares to cover all short positions.

Current Short Interest
3,500 shares
Previous Short Interest
500 shares
Change Vs. Previous Month
+600.00%
Dollar Volume Sold Short
$26,250.00
Short Interest Ratio
0.6 Days to Cover
Last Record Date
September 15, 2024
Outstanding Shares
67,344,000 shares
Percentage of Shares Shorted
0.01%
Today's Trading Volume
2,388 shares
Average Trading Volume
4,719 shares
Today's Volume Vs. Average
51%
Short Selling Pharming Group?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Pharming Group and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PHAR Short Interest Over Time

PHAR Days to Cover Over Time

PHAR Percentage of Float Shorted Over Time

Pharming Group Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/20243,500 shares $26,250.00 +600.0%N/A0.6 $7.50
8/31/2024500 shares $3,845.00 No ChangeN/A0.1 $7.69
8/15/2024500 shares $3,805.00 -87.5%N/A0.1 $7.61
7/31/20244,000 shares $34,200.00 +14.3%N/A0.6 $8.55
7/15/20243,500 shares $30,485.00 +20.7%N/A0.8 $8.71
6/30/20242,900 shares $24,215.00 -63.8%N/A0.6 $8.35
6/15/20248,000 shares $68,800.00 -22.3%N/A1.8 $8.60
5/31/202410,300 shares $94,245.00 +32.1%N/A2.8 $9.15
5/15/20247,800 shares $74,802.00 +100.0%N/A2.9 $9.59
4/30/20243,900 shares $36,621.00 +200.0%N/A1.4 $9.39
4/15/20241,300 shares $13,273.00 -13.3%N/A0.5 $10.21
3/31/20241,500 shares $16,260.00 -44.4%N/A0.6 $10.84
3/15/20242,700 shares $30,996.00 -10.0%N/A1.2 $11.48
2/29/20243,000 shares $34,350.00 +900.0%N/A1.3 $11.45
2/15/2024300 shares $3,315.00 -72.7%N/A0.2 $11.05
1/31/20241,100 shares $14,025.00 +57.1%N/A0.7 $12.75
1/15/2024700 shares $9,030.00 -30.0%N/A0.3 $12.90
12/31/20231,000 shares $11,430.00 +100.0%N/A0.4 $11.43
12/15/2023500 shares $5,900.00 -16.7%N/A0.2 $11.80
11/30/2023600 shares $6,738.00 +500.0%N/A0.2 $11.23
11/15/2023100 shares $1,147.00 -80.0%N/A0 $11.47
10/31/2023500 shares $5,800.00 -44.4%N/A0.1 $11.60
10/15/2023900 shares $10,800.00 -91.6%N/A0.3 $12.00
9/30/202310,700 shares $121,980.00 +269.0%N/A3.1 $11.40
9/15/20232,900 shares $39,150.00 +7.4%N/A1 $13.50
8/31/20232,700 shares $34,006.50 +68.8%N/A1.3 $12.60
8/15/20231,600 shares $19,206.72 +33.3%N/A0.7 $12.00
7/31/20231,200 shares $14,400.00 +300.0%N/A0.5 $12.00
7/15/2023300 shares $3,660.00 -76.9%N/A0.1 $12.20
6/30/20231,300 shares $15,145.00 -60.6%N/A0.3 $11.65
6/15/20233,300 shares $40,623.00 +17.9%N/A0.1 $12.31
5/31/20232,800 shares $33,600.00 +180.0%N/A0.1 $12.00
5/15/20231,000 shares $11,610.00 -37.5%N/A0 $11.61
4/30/20231,600 shares $17,792.00 -68.6%N/A0.1 $11.12
4/15/20235,100 shares $58,318.50 -68.5%N/A0.2 $11.44
3/31/202316,200 shares $218,700.00 +1,700.0%N/A0.7 $13.50
3/15/2023900 shares $10,971.00 -55.0%N/A0.1 $12.19
2/28/20232,000 shares $24,440.00 -33.3%N/A0.5 $12.22
2/15/20233,000 shares $39,390.00 +500.0%N/A0.6 $13.13
1/31/2023500 shares $6,685.00 +150.0%N/A0.1 $13.37
The Bible Says it Clear As Day (Ad)

It came to me clear-as-day thanks to the Bible… in the Parable of Talents, in the book of Matthew… This parable teaches us that it’s our duty, and our challenge, to grow our money … to invest it and put it to good use … rather than keeping it stuffed away in a savings account, or wasting it in some frivolous way. In this video, Wall Street expert Charles Mizrahi shows me a secret that has helped me … and tons of other hardworking Americans … learn to invest just like the pros on Wall

Click here to join me in the “Miracle on Main Street.”
1/15/2023200 shares $2,688.00 -85.7%N/A0 $13.44
12/30/20221,400 shares $15,442.00 -60.0%N/A0.2 $11.03
12/15/20223,500 shares $39,725.00 +52.2%N/A0.5 $11.35
11/30/20222,300 shares $28,658.00 No ChangeN/A0.3 $12.46
11/15/20222,300 shares $26,887.00 -11.5%N/A0.3 $11.69
10/31/20222,600 shares $25,194.00 -45.8%N/A0.4 $9.69
10/15/20224,800 shares $44,400.00 +182.4%N/A0.9 $9.25
9/30/20221,700 shares $16,728.00 -62.2%N/A0.3 $9.84
9/15/20224,500 shares $52,650.00 -56.7%N/A1.6 $11.70
8/31/202210,400 shares $125,944.00 +1,055.6%N/A3.3 $12.11
8/15/2022900 shares $9,873.00 +12.5%N/A0.3 $10.97
7/31/2022800 shares $6,092.64 -46.7%N/A0.3 $7.62
7/15/20221,500 shares $10,896.45 -42.3%N/A0.4 $7.26
6/30/20222,600 shares $22,776.00 -36.6%N/A0.7 $8.76
6/15/20224,100 shares $29,520.00 +215.4%N/A0.9 $7.20
5/31/20221,300 shares $10,569.00 -35.0%N/A0.3 $8.13
5/15/20222,000 shares $16,099.80 No ChangeN/A0.4 $8.05
4/30/20222,000 shares $16,604.40 -23.1%N/A0.4 $8.30
4/15/20222,600 shares $24,005.02 -36.6%N/A0.5 $9.23
3/31/20224,100 shares $36,859.00 +5.1%N/A0.8 $8.99
3/15/20223,900 shares $31,980.39 -29.1%N/A0.8 $8.20
2/28/20225,500 shares $50,875.00 -1.8%N/A1.1 $9.25
2/15/20225,600 shares $53,648.00 -45.1%N/A1.1 $9.58
1/31/202210,200 shares $91,494.00 +2.0%N/A1.6 $8.97
1/15/202210,000 shares $92,600.00 -33.3%N/A1 $9.26
12/31/202115,000 shares $134,100.00 +200.0%N/A1.5 $8.94
12/15/20215,000 shares $41,800.00 +2.0%N/A0.5 $8.36
11/30/20214,900 shares $39,396.00 -38.0%N/A0.6 $8.04
11/15/20217,900 shares $71,653.00 +14.5%N/A1 $9.07
10/29/20216,900 shares $62,100.00 -28.1%N/A1 $9.00
10/15/20219,600 shares $90,624.00 +966.7%N/A9.6 $9.44
9/30/2021900 shares $8,550.00 +350.0%N/A1 $9.50
9/15/2021200 shares $1,940.00 -77.8%N/A0.2 $9.70
8/31/2021900 shares $9,945.00 +350.0%N/A0.7 $11.05
8/13/2021200 shares $2,108.00 No ChangeN/A0.1 $10.54
5/28/20217,900 shares $95,985.00 -11.2%N/A3 $12.15
5/14/20218,900 shares $105,999.00 +17.1%N/A2.2 $11.91
4/30/20217,600 shares $97,432.00 +660.0%N/A1.5 $12.82
4/15/20211,000 shares $13,000.00 -92.3%N/A0.2 $13.00
3/31/202112,900 shares $167,958.00 -65.6%N/A1.7 $13.02
3/15/202137,500 shares $503,625.00 +229.0%N/A1.2 $13.43
2/26/202111,400 shares $154,584.00 -5.8%N/A0.3 $13.56
2/12/202112,100 shares $168,069.00 +450.0%N/A0.3 $13.89
1/29/20212,200 shares $32,120.00 +57.1%N/A0 $14.60
1/15/20211,400 shares $19,320.00 No ChangeN/A0 $13.80

PHAR Short Interest - Frequently Asked Questions

What is Pharming Group's current short interest?

Short interest is the volume of Pharming Group shares that have been sold short but have not yet been closed out or covered. As of September 15th, traders have sold 3,500 shares of PHAR short. Learn More on Pharming Group's current short interest.

What is a good short interest ratio for Pharming Group?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PHAR shares currently have a short interest ratio of 1.0. Learn More on Pharming Group's short interest ratio.

Is Pharming Group's short interest increasing or decreasing?

Pharming Group saw a increase in short interest in September. As of September 15th, there was short interest totaling 3,500 shares, an increase of 600.0% from the previous total of 500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Pharming Group's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Pharming Group: Janux Therapeutics, Inc. (8.57%), Verona Pharma plc (10.89%), Harmony Biosciences Holdings, Inc. (27.39%), Keros Therapeutics, Inc. (9.70%), Maravai LifeSciences Holdings, Inc. (3.14%), Akero Therapeutics, Inc. (10.35%), Structure Therapeutics Inc. (19.28%), Mirum Pharmaceuticals, Inc. (14.96%), Galapagos NV (2.28%), Ligand Pharmaceuticals Incorporated (5.43%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($6.15 billion), Charter Communications, Inc. ($4.04 billion), Paychex, Inc. ($2.77 billion), Nu Holdings Ltd. ($2.71 billion), Cencora, Inc. ($2.34 billion), Aptiv PLC ($2.18 billion), Tractor Supply ($2.07 billion), International Paper ($2.01 billion), AppLovin Co. ($1.95 billion), and Moderna, Inc. ($1.89 billion). View all of the most shorted stocks.

What does it mean to sell short Pharming Group stock?

Short selling PHAR is an investing strategy that aims to generate trading profit from Pharming Group as its price is falling. PHAR shares are trading down $0.41 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Pharming Group?

A short squeeze for Pharming Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PHAR, which in turn drives the price of the stock up even further.

How often is Pharming Group's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PHAR, twice per month. The most recent reporting period available is September, 15 2024.




This page (NASDAQ:PHAR) was last updated on 10/5/2024 by MarketBeat.com Staff
From Our Partners